Found 47 matching trials
Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor
PHASE2This is a phase II, single-arm, open-label study to evaluate the efficacy a...
Location
Shanghai Pulmonary Hospital
Neoadjuvant Toripalimab + Chemotherapy ± Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma (Neo-ICT)
PHASE3This study is a randomized, active-controlled, open-label clinical trial fo...
Location
Multiple Locations
Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Esophageal Carcinoma
PHASE1This prospective study aims to clarify the clinical efficacy and survival p...
Neoadjuvant Toripalimab Plus Platinum-based Doublet for Stage III Non-small Cell Lung Cancer
PHASE2This is an open-label, single-arm, phase II, multi-center clinical trial. T...
Location
Sun Yat sen University cancer center
Window of Opportunity in Preserving Laryngeal Function Trial
PHASE2This trial will study the safety and tolerability and disease survival rate...
Location
UPMC Hillman Cancer
A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors
PHASE1This is a phase I/II study to preliminarily explore of the safety, tolerabi...
Location
Cancer Hospital Chinese Academy of Medical Sciences
Neoadjuvant Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms
PHASE2This proposed study will evaluate the efficacy and safety of preoperative a...
Location
Sun Yat-sen Memorial Hospital
Toripalimab With Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
PHASE2This is a single-institution, single arm trial of Toripalimab with neoadjuv...
Location
Sichuan Cancer Hospital and Research Institute
Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer
PHASE2This is a single-center phase 2 study of to test how well the combination o...
Location
The University of Chicago Medicine Comprehensive Cancer Center
Neoadjuvant Anti-PD-1 Antibody (Toripalimab) or Combined With Chemotherapy in HNSCC Patients
PHASE2This study evaluate either Toripalimab or combined with chemotherapy as neo...
Location
Department of Medical Onocology, First Affiliated Hospital of Zhejiang University